QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.052092v1 311/2/427    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heinrichs, S. C. Articles by Koob, G. F. Search for Related Content PubMed PubMed Citation Articles by Heinrichs, S. C. Articles by Koob, G. F. Pubmed/NCBI databases Substance via MeSH

PERSPECTIVES IN PHARMACOLOGY

Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation

Boston College, Department of Psychology, Chestnut Hill, Massachusetts (S.C.H.); and The Scripps Research Institute, Department of Neuropharmacology, La Jolla, California (G.F.K.)

Organisms exposed to challenging stimuli that alter the status quo inside or outside of the body are required for survival purposes to generate appropriate coping responses that counteract departures from homeostasis. Identification of an executive control mechanism within the brain capable of coordinating the multitude of endocrine, physiological, and functional coping responses has high utility for understanding the response of the organism to stressor exposure under normal or pathological conditions. The corticotropin-releasing factor (CRF)/urocortin family of neuropeptides and receptors constitutes an affective regulatory system due to the integral role it plays in controlling neural substrates of arousal, emotionality, and aversive processes. In particular, available evidence from pharmacological intervention in multiple species and phenotyping of mutant mice shows that CRF/urocortin systems mediate motor and psychic activation, stimulus avoidance, and threat recognition responses to aversive stimulus exposure. It is suggested that affective regulation is exerted by CRF/urocortin systems within the brain based upon the sensitivity of local brain sites to CRF/urocortin ligand administration and the appearance of hypothalamo-pituitary-adrenocortical activation following stressor exposure. Moreover, these same stress neuropeptides may constitute a mechanism for learning to avoid noxious stimuli by facilitating the formation of so-called emotional memories. A conceptual framework is provided for extrapolation of animal model findings to humans and for viewing CRF/urocortin activation as a continuum measure linking normal and pathological states.

Address correspondence to. Dr. George F. Koob, The Scripps Research Institute, Department of Neuropharmacology, CVN-7, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: gkoob{at}scripps.edu

This article has been cited by other articles:

				R. Pastor, C. S. McKinnon, A. C. Scibelli, S. Burkhart-Kasch, C. Reed, A. E. Ryabinin, S. C. Coste, M. P. Stenzel-Poore, and T. J. Phillips From the Cover: Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism PNAS, July 1, 2008; 105(26): 9070 - 9075. [Abstract] [Full Text] [PDF]

				R. G. Bradley, E. B. Binder, M. P. Epstein, Y. Tang, H. P. Nair, W. Liu, C. F. Gillespie, T. Berg, M. Evces, D. J. Newport, et al. Influence of Child Abuse on Adult Depression: Moderation by the Corticotropin-Releasing Hormone Receptor Gene Arch Gen Psychiatry, February 1, 2008; 65(2): 190 - 200. [Abstract] [Full Text] [PDF]

				D. A. Slattery and I. D. Neumann No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain J. Physiol., January 15, 2008; 586(2): 377 - 385. [Abstract] [Full Text] [PDF]

				O. George, S. Ghozland, M. R. Azar, P. Cottone, E. P. Zorrilla, L. H. Parsons, L. E. O'Dell, H. N. Richardson, and G. F. Koob CRF CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats PNAS, October 23, 2007; 104(43): 17198 - 17203. [Abstract] [Full Text] [PDF]

				G. Koob and M. J. Kreek Stress, Dysregulation of Drug Reward Pathways, and the Transition to Drug Dependence Am J Psychiatry, August 1, 2007; 164(8): 1149 - 1159. [Abstract] [Full Text] [PDF]

				D. R. Gehlert, A. Cippitelli, A. Thorsell, A. D. Le, P. A. Hipskind, C. Hamdouchi, J. Lu, E. J. Hembre, J. Cramer, M. Song, et al. 3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism J. Neurosci., March 7, 2007; 27(10): 2718 - 2726. [Abstract] [Full Text] [PDF]

				M. F. Mesleh, W. A. Shirley, C. E. Heise, N. Ling, R. A. Maki, and R. P. Laura NMR Structural Characterization of a Minimal Peptide Antagonist Bound to the Extracellular Domain of the Corticotropin-releasing Factor1 Receptor J. Biol. Chem., March 2, 2007; 282(9): 6338 - 6346. [Abstract] [Full Text] [PDF]

				A. C. Hansson, A. Cippitelli, W. H. Sommer, A. Fedeli, K. Bjork, L. Soverchia, A. Terasmaa, M. Massi, M. Heilig, and R. Ciccocioppo Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress PNAS, October 10, 2006; 103(41): 15236 - 15241. [Abstract] [Full Text] [PDF]